Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01093625 · ClinicalTrials.gov registry record · NA
Assessment of Daily Disposable Silicone Hydrogel Lens Wear
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 157
- Enrollment target
NCT01093625: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT01093625 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 157 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01093625, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of an investigational silicone hydrogel soft contact lens on new contact lens wearers (neophytes) compared to a control of spectacle wearers.
Primary Outcome
Swelling of the papillary (Papillary conjunctivitis) area of the eye was assessed using a slit-lamp. Comparison between the two study arms will be assessed using data generated from a slit-lamp examination, using an Efron scale with 0.1 unit increments. The Efron scale has a range of 0 (normal) to 4 (Severe) and is subjectively assessed for 0.1 increments by the clinician, with the higher the magnitude of the number the worse the score.
Interventions
- DEVICE Spectacles
- DEVICE Narafilcon B Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01093625 record still lists
NCT01093625 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Spectacles is the first listed.
NCT01093625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01093625 about?
NCT01093625 is a clinical study titled "Assessment of Daily Disposable Silicone Hydrogel Lens Wear". The purpose of this study is to evaluate the effect of an investigational silicone hydrogel soft contact lens on new contact lens wearers (neophytes) compared to a control of spectacle wearers.
What is the current status of trial NCT01093625?
This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2010-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01093625?
The interventions under investigation include: Spectacles (DEVICE), Narafilcon B Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT01093625?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01093625's enrollment target sits among peer trials
157 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia